ReviewClinical and experimental nephrology2024

The role of a novel mineralocorticoid receptor antagonist, finerenone, in chronic kidney disease: mechanisms and clinical advances.

Xinping Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.